Glenmark Pharmaceuticals share news, announcements and annual reports
NSE: GLENMARKBSE: 532296Pharmaceuticals & BiotechnologyMid Cap
Glenmark Pharmaceuticals Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹2,298.70down ₹40.30 (1.72%)BSE ₹2,308.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹2,339.00.
30 Oct: open ₹2,336.00, high ₹2,337.30, low ₹2,291.30
52-week range of traded prices to 30 Oct 2026
₹1,801.40Low, 7 Nov 2025₹2,537.60High, 28 Aug 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹64,875 Cr176th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 36.08
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1,943 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 17.34
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 6.17
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.11%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 18.6%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1,943 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 38.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 39.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,28,88751.5% delivered
Glenmark Pharmaceuticals shareholder meetings
83 filed, newest first. Page 2 of 2.
Apr 2015
Nov 2014
28 Nov · Meeting
Oct 2014
22 Oct · Meeting
Aug 2014
Jul 2014
25 Jul · Meeting
At the Annual General Meeting held on July 25, 2014 the shareholders have approved following: Dividend of Rs. 2 per share of Re. 1 each (200%) on the Equity Share Capital of the Company for the financial year ended 2013-2014.
Aug 2013
Jul 2013
5 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from July 22, 2013 to August 02, 2013 (both days inclusive) for the purpose of the Annual Closure for the Annual General Meeting scheduled to be held on August 02, 2013 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting is payable.
Aug 2012
8 Aug · Meeting
At the Annual General Meeting held on August 03, 2012 the Shareholders have approved the following : Dividend of Rs. 2/- per share of Re.1 each (200%) on the Equity Share Capital of the Company for the financial year ended 2011-12.
Jul 2012
4 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from July 23, 2012 to August 03, 2012 (both days inclusive) for the purpose of the Annual Closure for the Annual General Meeting scheduled to be held on August 03, 2012 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting is payable.
Aug 2011
11 Aug · Meeting
At the Annual General Meeting held on August 11, 2011, the Shareholders have approved the following : Dividend of Re. 0.40 per share of Re.1 each (40%) on the Equity Share Capital of the Company for the financial year ended 2010-2011.
Jul 2011
18 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from August 01, 2011 to August 11, 2011 (both days inclusive) for the purpose of the Annual Closure for the Annual General Meeting scheduled to be held on August 11, 2011 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting is payable.
Oct 2010
Sep 2010
27 Sep · Meeting
At the Annual General Meeting held on September 27, 2010, the shareholders have approved the following: (1) Final Dividend @ 40% on the Equity Share Capital of the Company for the financial year ended 2009-2010.(2) Appointment of Walker, Chandiok & Co, Chartered Accountants as Statutory Auditors of the Company for the Financial Year 2010-2011.1 Sep · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from September 20, 2010 to September 27, 2010 (both days inclusive) for the purpose of the Annual Closure for the Annual General Meeting scheduled to be held on September 27, 2010 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting is payable.
Oct 2009
23 Oct · Meeting
Glenmark Pharmaceuticals Ltd. has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the members of the Company held on September 25, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
17 Sep · Meeting
Glenmark Pharmaceuticals Ltd.has submitted to the Exchange a copy of the proceedings of the Deemed Extra Ordinary General Meeting of the Company held on September 02, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Sep · Meeting
Glenmark Pharmaceuticals Ltd. has submitted to the Exchange a copy of Notice of the Annual General Meeting of the Members of the Company to be held on September 25, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Sep · Meeting
Glenmark Pharmaceuticals Ltd. has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will remain closed from September 14, 2009 to September 25, 2009 (both days inclusive) for the purpose of the Annual Closure for the Annual General Meeting scheduled to be held on September 25, 2009 and also for determining the names of the shareholders to whom the dividend which if declared at the Annual General Meeting is payable.
Aug 2009
6 Aug · Meeting
Glenmark Pharmaceuticals Ltd. has submitted to the Exchange a copy of the Notice of Postal Ballot Pursuant to Section 192A(2) of the Companies Act, 1956. A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
3 Oct · Meeting
Glenmark Pharmaceuticals Ltd. has submitted to the Exchange a copy of the proceedings of the Annual General Meeting of the Company held on September 26, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
2 Sep · Meeting
Glenmark Pharmaceuticals Ltd. has informed the Exchange that 1)The Annual General Meeting of the Company will be held on September 26, 2008. 2) The Register of Members and Transfer Book of the Company shall remain closed from September 22, 2008 to September 26, 2008 (both days inclusive).1 Sep · Meeting
Glenmark Pharmaceuticals Ltd. has informed the Exchange that pursuant to the provisions of section 192A(2) of the Act read together with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001, the consent of the shareholders to be obtained by means of Postal Ballot. (1) Consent pursuant to the provisions of section 372A to make loans, give guarantees upto a limit not exceeding Rs.4000 Crores. (2) Consent pursuant to section 293(1)(d) to borrow upto Rs.4000 Crores. (3) Consent pursuant to section 293(1)(a) of the Companies Act, to create a mortgage and / or charge over all the movable and immovable properties of the Company. The Company has appointed Mr. Surjan Singh Rauthan, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting the Postal Ballot in a fair and transparent manner. The Postal Ballot Form duly completed and signed should reach the Scrutinizer on or before the close of working hours on September 29, 2008. The Scrutinizer shall submit his report to the Chairman of the Company after the completion of the scrutiny and the results of the Postal Ballot shall be announced on October 06, 2008. A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
28 Feb · Meeting
Glenmark Pharmaceuticals Ltd. has submitted to the Exchange a copy of the proceedings of the Deemed EGM held on February 5,2008 for declaring the results of Postal Ballot.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Dec 2007
31 Dec · Meeting
Glenmark Pharmaceuticals Ltd. has informed the Exchange that pursuant to the provisions of section 192A(2) of the Act read together with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001, the consent of the shareholders to be obtained by means of Postal Ballot for the aforesaid purpose (as per attachments).The Company has appointed Mr.Surjan Singh Rauthan, Practicing Company Secretary, Mumbai, as the Scrutinizer for conducting the Postal Ballot in a Fair and transparent manner. The Postal Ballot Form duly completed and signed should reach the Scrutinizer on or before the close of working hours on January 30, 2008. The Scrutinizer shall submit his report to the Chairman of the Company after the completion of the scrutiny and the results of the Postal Ballot shall be announced on February 05, 2008. A copy of the postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
30 Aug · Meeting
Glenmark Pharmaceuticals Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on September 20, 2007.
Jun 2007
25 Jun · Meeting
Glenmark Pharmaceuticals Ltd. has informed the Exchange regarding the Postal Ballot pursuant to Section 192A of the Companies act, 1956 read with the Companies (Passing of Resolution by Postal ballot ) Rules, 2001 to transact the Special Business by the Members by passing Resolution through Postal Ballot. The Company has appointed Mr. Surjan Singh Rauthan, Practising Company Secretary, Mumbai, as the Scrutinizer for conducting the Postal Ballot in a fair and transparent manner. The duly completed Postal Ballot Form in the enclosed self addressed pre-paid postage envelope reaches the Scrutinizer on or before the close of working hours on July 24, 2007. The Scrutinizer shall submit his report to the Chairman of the Company after completion of the scrutiny and the results of the Postal Ballot shall be announced on July 27, 2007 at the Corporate office of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.